![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
December 23, 2024
The co-chairs reflect on the past year in cancer research and make the case for embracing the inclusion of real-world data in ECOG-ACRIN
November 25, 2024
Fall Group Meeting highlights; impactful results in head and neck cancer; a ComboMATCH update
October 17, 2024
The co-chairs reflect on how the cancer research landscape has evolved over the last five years
September 17, 2024
Fall Comis Symposium to focus on inflammation as a cause of cancer; ECOG-ACRIN readies for NCTN Grant resubmission
August 14, 2024
Thoughts on the evolving clinical cancer research environment—and practice-changing results in acute lymphoblastic leukemia
July 3, 2024
GI Cancer Committee displays strong representation at ASCO; real-world data study nears activation; ECOG-ACRIN commends NCI's appointment of senior advisor for clinical research
June 11, 2024
A Spring Group Meeting recap; a milestone for TMIST; a new myeloMATCH treatment trial
May 1, 2024
A new trial in sarcoma; MSI testing for gastroesophageal cancer; Spring Group Meeting and ASCO highlights
April 9, 2024
A new trial in glioblastoma; leadership transitions; upcoming Group Meeting highlights
March 7, 2024
Big data projects near activation; APP Working Group builds momentum; ECOG-ACRIN welcomes Winn CILA scholar
February 9, 2024
The co-chairs commemorate the late Dr. Edith Mitchell, welcome the new NCI Director, and reflect on the DREAMseq melanoma trial results
December 19, 2023
The co-chairs reflect on the year's key accomplishments and look ahead to 2024